Displaying 69 out of 203 Cambridge companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
PragmatIC Semiconductor

Silicon-free chip maker.

46
$228M · Series D Latitude, UK Infrastructure Bank, MVolution Partners 101 to 250 Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@pragmaticsemi.com
Theia Insights

AI-powered investment analytics platform.

42
$6M · Series A Fidelity International Strategic Ventures, Unusual Ventures, Clocktower Technology Ventures 1 to 10 AI, Investing B2B, SaaS Cambridge, UK •••••••••••@theiainsights.com
Qureight

Imaging analytics platform that processes and analyzes medical images.

42
$8M · Series A Ascension Ventures, Guinness Ventures, Hargreave Hale Aim VCT 1 to 10 Health Tech, Machine Learning, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@qureight.com
CMR Surgical

Surgical robotic system for minimal access surgery.

42
$164M · Series D SoftBank Group, Tencent, ABB Technology Ventures 501 to 1000 Health Tech, Robotics B2B Cambridge, UK •••••••••••@cmrsurgical.com
PlaqueTecJUST ADDED HIRING

Bioinformatics discovery platform.

42
$8M · Series A Future Fund 1 to 10 Biotech, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@plaquetec.com
Fuse DiagnosticsJUST ADDED HIRING

Industrial diagnostic testing platform.

42
$2M · Seed Innovate UK 1 to 10 Health Tech B2B Cambridge, UK •••••••••••@fuse-dx.com
Healx

Platform for discovering new drugs for rare diseases using AI technology.

37
$56M · Series B Balderton Capital, Atomico, btov Partners 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
Sano Genetics

AI platform to advance precision medicine clinical trials.

37
$11M · Series A Seedcamp, Plural, Episode 1 11 to 50 Health Tech, Biotech B2B, SaaS Cambridge, UK •••••••••••@sanogenetics.com
Devo

Cybersecurity platform providing cloud-native logging and security analytics for organizations.

37
$100M Bessemer Venture Partners, Kibo Ventures, Insight Venture Partners 251 to 500 Cybersecurity, Data and Analytics, Privacy and Security, Business Intelligence, Developer Tools, Cloud B2B, SaaS Cambridge, UK •••••••••••@devo.com
ViaNautis

Drug delivery platform.

37
$24M · Series A 4BIO Capital, UCB Ventures, Business Growth Fund 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@vianautis.com
ieso

Transforming mental healthcare by unlocking the power of clinical data

37
$52M · Series B Molten Ventures 101 to 250 Health Tech, Deep Tech B2B, B2C Cambridge, UK •••••••••••@iesogroup.com
NeoPhore

Small molecule neoantigen immuno-oncology therapies developer.

37
$12M · Series B Sixth Element Capital, 3B Future Health Fund, Astellas Venture Management 1 to 10 Health Tech Cambridge, UK •••••••••••@neophore.com
Kubos Semiconductors HIRING

Cubic-GaN technology designed for efficient, low-cost LEDs leveraging proprietary intellectual property.

37
$1M · Seed FOV Ventures, Development Bank of Wales Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@kubos-semi.com
Uncommon

Cultured meat manufacturer.

37
$30M · Series A Balderton Capital, Lowercarbon Capital 11 to 50 Climate Tech & Green Tech, Foodtech Cambridge, UK •••••••••••@uncommonbio.co
Microbiotica

Human microbiome therapeutics developer creating live bacterial treatments and biomarkers.

37
$66M Seventure Partners, Cambridge Innovation Capital 11 to 50 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@microbiotica.com
bit.bio

Platform for understanding and defining the biological codes that make up human cells.

31
$41M · Series A Metaplanet Holdings, BlueYard Capital 101 to 250 Health Tech, Biotech, Deep Tech, Business Intelligence B2B Cambridge, UK •••••••••••@bit.bio
Unitary

AI-driven visual content moderation platform.

31
$15M · Series A January Ventures, Creandum, Plural 11 to 50 AI, Sales and Marketing B2B, SaaS Cambridge, UK •••••••••••@unitary.ai
Endomag

Medical technology improving breast cancer care through magnetic sensing innovations.

31
$20M · Series D Molten Ventures 51 to 100 Health Tech, Hardware B2B Cambridge, UK •••••••••••@endomag.com
Risilience

Climate analytics and risk assessement.

31
$26M · Series B IQ Capital Partners 11 to 50 Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@risilience.com
Nu Quantum

Telecommunications company developing end-to-end quantum cryptography systems.

31
$7M · Seed Expeditions Fund, Amadeus Capital, IQ Capital Partners 1 to 10 Hardware, Cybersecurity, Manufacturing, Communications B2B Cambridge, UK •••••••••••@nu-quantum.com
Mosaic Therapeutics

Anti-cancer drug developer.

31
$28M · Series A Syncona Partners LLP, Cambridge Innovation Capital 101 to 250 Biotech Cambridge, UK •••••••••••@mosaic-tx.com
Nuclera

Desktop technology making biology accessible by synthesizing proteins and genes.

31
$42M · Series B Future Planet Capital, Amadeus Capital, Verve Ventures 11 to 50 Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@nuclera.com
Secondmind

Machine learning for automotive innovators

31
$16M · Series A Amadeus Capital, Cambridge Innovation Capital, Atlantic Bridge 51 to 100 AI Cambridge, UK •••••••••••@secondmind.ai
Mogrify

Platform enabling the development of cell therapies through advanced reprogramming techniques.

31
$10M · Series A Astellas Venture Management, Parkwalk Advisors, Ahren Innovation Capital 101 to 250 Health Tech, Biotech, Deep Tech B2B Cambridge, UK •••••••••••@mogrify.co.uk
Broken String Biosciences

Genomics company building safer cell and gene therapies.

31
$15M · Series A Tencent, Illumina Ventures 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@brokenstringbio.com
Zetta Genomics

Genomic data analysis platform.

31
$2M · Seed We Venture Capital, Nina Capital, LinkedIn 11 to 50 Biotech, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@zettagenomics.com
Metrion Biosciences

Contract Research Organization specializing in bioscience research services.

31
$4M · Series A Gresham House Ventures, NPIF Maven Equity Finance 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@metrionbiosciences.com
Supplant

"Biotechnology platform producing sugar substitutes."

31
$24M Khosla Ventures, Felicis Ventures, Y Combinator 11 to 50 Health Tech, Foodtech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@supplant.com
evonetix

DNA synthesis technology researcher.

31
$24M · Series B Foresite Capital 11 to 50 Biotech Cambridge, UK •••••••••••@evonetix.com
Harness Therapeutics

Physiological upregulation therapy to treat neurodegenerative diseases.

31
$5M · Seed SV Health Investors 11 to 50 Health Tech, Biotech Cambridge, UK •••••••••••@harnesstx.com
Qkine

Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.

26
$5M · Series B Parkwalk Advisors, Downing Ventures 11 to 50 Biotech, Deep Tech Cambridge, UK •••••••••••@qkine.com
GeoSpock

Database specializing in space-time analytics, providing rapid insights at a fraction of the cost.

26
$5M Parkwalk Advisors 11 to 50 Climate Tech & Green Tech, Fintech, Mobile, Data and Analytics, Business Intelligence, Internet of Things, Developer Tools, Cloud B2B, SaaS Cambridge, UK •••••••••••@geospock.com
Cake

Platform for helping people navigate end-of-life.

26
$14M Creandum, Headline 1 to 10 Health Tech, Mobile, Mobility & Transportation, Manufacturing, Sales and Marketing B2C Cambridge, UK •••••••••••@joincake.com
Riverlane

OS for quantum computers.

26
$18M · Series B Molten Ventures, Amadeus Capital, Cambridge Innovation Capital 11 to 50 B2B Cambridge, UK •••••••••••@riverlane.com
Flusso

Flow sensor technology focused on creating the world's smallest device.

26
$5M · Series A Parkwalk Advisors, Martlet Capital 11 to 50 Navigation and Mapping, Manufacturing B2B Cambridge, UK •••••••••••@flussoltd.com
Cydar Medical

Precision software for surgeries.

26
$11M · Series A Pembroke VCT 11 to 50 Health Tech B2B, SaaS Cambridge, UK •••••••••••@cydarmedical.com
Nyobolt

Developer of high-powered battery technology for automotive applications.

26
$10M · Series A IQ Capital Partners 11 to 50 Climate Tech & Green Tech, Energy & Nuclear, Manufacturing B2B Cambridge, UK •••••••••••@nyobolt.com
Forefront RF

Semiconductor developer.

26
$8M · Series A Business Growth Fund 11 to 50 Hardware, Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@forefrontrf.com
Eagle Genomics

Platform that helps manage and analyze life sciences data for organizations.

26
$3M · Seed ETF Partners, Granpool Innovative Investments 11 to 50 Health Tech, Biotech B2B Cambridge, UK •••••••••••@eaglegenomics.com
PillSorted

Pharmacy service that combines caring customer support with modern technology for a personalized experience.

26
$6M · Seed Hoxton Ventures 11 to 50 Health Tech, CPG & Consumer Goods, Pharma, Ecommerce B2B, B2C, SaaS Cambridge, UK •••••••••••@pillsorted.com
Cambridge GaN Devices

Transistors designed to integrate GaN technology into everyday consumer electronics.

26
$19M IQ Capital Partners, Cambridge Innovation Capital, Business Growth Fund 11 to 50 Manufacturing B2B Cambridge, UK •••••••••••@camgandevices.com
Cyted

Cancer diagnostics.

26
$16M · Series A Business Growth Fund 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@cyted.ai
TidalSense

AI-driven tech for respiratory conditions.

26
$9M · Series A Business Growth Fund, Downing Ventures 11 to 50 Health Tech, AI Cambridge, UK •••••••••••@tidalsense.com
Epitopea

Cancer immunotherapeutics company working across the Atlantic.

26
$13M · Seed Cambridge Innovation Capital 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@epitopea.com
Abzena

Drug manufacturer.

26
$10M · Series A Biospring Partners 501 to 1000 Health Tech, Biotech, Pharma B2B, SaaS Cambridge, UK •••••••••••@abzena.com
Mestag Therapeutics

Fibroblast technology designed to develop new therapies for diseases.

26
$11M · Seed GV, Forbion Capital Partners 1 to 10 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@mestagtx.com
MISSION Therapeutics

Deubiquitylating enzyme (DUB) drug discovery and development platform.

26
$6M · Series A Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments 51 to 100 Health Tech, Biotech Cambridge, UK •••••••••••@missiontherapeutics.com
Pivotal

Biodiversity measurement platform.

26
$5M · Seed Octopus Ventures 11 to 50 Climate Tech & Green Tech Cambridge, UK •••••••••••@pivotal.earth
Speechmatics

Software offering autonomous speech and voice recognition for live and recorded media.

26
$8M · Series A AlbionVC, IQ Capital Partners 101 to 250 Music and Audio, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@speechmatics.com
Agile Analog

Supplier of configurable process node agnostic analog IP building blocks.

26
$5M · Seed Omers Ventures, Firstminute Capital, MMC Ventures 11 to 50 Deep Tech, Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@agileanalog.com
Axol Bioscience

Live human cell cultures and genome editing services for researchers.

26
$5M Calculus Capital 11 to 50 Health Tech, Biotech, Pharma, Business Intelligence B2B Cambridge, UK •••••••••••@axolbio.com
PetMedix

Pet therapeutics startup dedicated to developing medicines for pets.

26
$13M · Series A Cambridge Innovation Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@petmedix.co.uk
Foundries.io

Platform offering secure, over-the-air updatable software for embedded product development.

26
$8M · Series A BACKED VC, Crane Venture Partners, IQ Capital Partners 11 to 50 B2B, SaaS Cambridge, UK •••••••••••@foundries.io
Owlstone Medical

Breathalyzer technology for non-invasive detection of infectious diseases.

23
$57M · Series D 101 to 250 Health Tech Cambridge, UK •••••••••••@owlstonemedical.com
Gearset

Setting the standard for Salesforce DevOps

23
$55M 101 to 250 Sales and Marketing, Developer Tools B2B, SaaS Cambridge, UK •••••••••••@gearset.com
Artios Pharma

Independent biotech company focused on developing new cancer therapies targeting DNA damage response.

23
$152M · Series C 101 to 250 Health Tech, Deep Tech Cambridge, UK •••••••••••@artiospharma.com
Cambridge Epigenetix

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

23
$88M · Series D 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@cambridge-epigenetix.com
Signaloid

Cloud-based computing platform.

21
$3M · Seed IQ Capital Partners, Creator Fund 11 to 50 Hardware, Manufacturing B2B Cambridge, UK •••••••••••@signaloid.ai
HexagonFab

Biological sensor enabling quick and affordable detection of biological substances.

21
$2M · Seed Parkwalk Advisors 1 to 10 Hardware, Biotech, Manufacturing, Business Intelligence B2B Cambridge, UK •••••••••••@hexagonfab.com
Semarion

Platform utilizing microfabrication technology to create smart materials for innovative cell testing.

21
$2M · Seed Parkwalk Advisors, Martlet Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B Cambridge, UK •••••••••••@semarion.com
Fieldwork Robotics

Manufacturer of autonomous harvesting robots.

21
$1M · Seed Elbow Beach Capital 1 to 10 Robotics, Manufacturing B2B Cambridge, UK •••••••••••@fieldworkrobotics.com
Luminance HIRING

Generative AI platform for law firms.

21
$3M · Seed Talis Capital, National Grid Partners (NGP), March Capital 101 to 250 AI, Legal Tech B2B, SaaS Cambridge, UK •••••••••••@luminance.com
Sphere Fluidics

Platform specializing in single cell analysis and characterization, offering related R&D services.

21
$4M Sofinnova Partners 11 to 50 Health Tech, Deep Tech B2B Cambridge, UK •••••••••••@spherefluidics.com
World Makers

Social multi-player gaming studio.

21
$4M · Series A Makers Fund 1 to 10 Foodtech, Gaming, CPG & Consumer Goods, Consumer Social, Community & Lifestyle B2C Cambridge, UK •••••••••••@worldmakers.com
techspert

Platform for identifying and sourcing specialist expertise globally using AI technology.

21
$4M · Series A Nauta Capital, Business Growth Fund 51 to 100 AI, Business Intelligence B2B, SaaS, Marketplace Cambridge, UK •••••••••••@techspert.com
Xampla

Plant-based biodegradable material producer.

21
$2M · Seed Amadeus Capital, Horizons Ventures, Parkwalk Advisors 1 to 10 Biotech B2B Cambridge, UK •••••••••••@xampla.com
KisanHub

Platform helping Producer Groups improve their agri-food supply chains.

21
$4M · Series A Notion Capital, IQ Capital Partners 11 to 50 Climate Tech & Green Tech, Agritech B2B, SaaS Cambridge, UK •••••••••••@kisanhub.com
DataQube Global

DataQube is the developer of 5G enabled edge data centre.

20
$29M · Series A 11 to 50 Cambridge, UK •••••••••••@dataqube.global
Storm Therapeutics

Novel cancer therapies.

20
$30M · Series B 11 to 50 Health Tech, Deep Tech B2C Cambridge, UK •••••••••••@stormtherapeutics.com
OTHER CITIES
OTHER CITIES IN UK